Barring unforeseen circumstances
With the global dental implant market expected to grow at 3-4% in 2017, the Straumann Group is confident that it can continue to outperform and expects to achieve full-year organic revenue growth of 13-15%. Despite further investments in strategic initiatives and manufacturing capacity expansion, the expected organic revenue growth and operational leverage shouldlead to further improvements in the underlying1 operating profit margin (2016: 24.8%), assuming that currency exchange rates remain fairly stable.
1 Excluding acquisition (Equinox, Medentika, ClearCorrect, and Dental Wings) and currency effects.
Initial guidance (February 2017)
The Straumann Group expects the global implant market to grow at a similar rate (3-4%) in 2017 and is confident that it can continue to outperform by achieving organic revenue growth in the high-single-digit range. Despite further investments in strategic growth initiatives and assuming that currency exchange rates remain fairly stable, the expected revenue growth and operational leverage should lead to further improvements in the (organic) operating profit margin.